“Relaxin-2”的搜索结果，显示 61-70 项，共有 7272 项

1. 血液科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

3. Mayo Clinic Neurosciences Physician Update � March 2026

   Page 1.

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

5. 血液科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

6. 心血管医学- 临床试验- 妙佑医疗国际

   The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...

7. 肺科- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · NextNext Page. 以下为当前的临床试验。 26 研究肺科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 A Study To Evaluate ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... 2 or 3 meningioma as measured by 6-month PFS rate. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders. Jacksonville, Fla. The ...

9. 神经外科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...